Synthesis of 4-guanidino-7-modified-Neu5Ac2en derivatives and their biological activities as influenza sialidase inhibitors

Substitution of 7–OH with small hydrophobic groups on zanamivir resulted in the retention of low nanomolar inhibitory activities against not only influenza A virus sialidase but also influenza A virus in cell culture. These compounds were prepared by treatment of the corresponding 7–substituted sialic acids derived from 4–modified N–acetyl–D–mannosamine (ManNAc) using enzyme–catalyzed aldol condensation.    A series of 7–alkyl ether derivatives related to Zanamivir were synthesized using direct alkylation of the C–7 alcohol of sialic acid. An alkyl ether moiety of less than 12 carbons in length showed low nanomolar inhibitory activity against influenza A virus sialidase. A series of ester prodrugs of compound (10b) was synthesized and their efficacy was evaluated in an influenza infected mouse model by intranasal administration. The compound (25c: CS–8958), octanoyl ester prodrug of the C–9 alcohol of compound (10b), was found to be much longer acting than Zanamivir. Polyvalent sialidase inhibitors bearing 4–guanidino–Neu5Ac2en analogues on the polyglutamic acid backbone, via a spacer of alkyl ether at the C–7 position, were synthesized. The multivalent conjugates (32) and (33) showed enhancement of antiviral activity against influenza A virus and more potent efficacy in vivo re-lative to monomeric sialidase inhibitors.

[1]  Mitsuru Hashida,et al.  Development and Pharmacokinetics of Galactosylated Poly-L-Glutamic Acid as a Biodegradable Carrier for Liver-Specific Drug Delivery , 1996, Pharmaceutical Research.

[2]  M. Yamashita,et al.  Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives. , 2003, Chemical & pharmaceutical bulletin.

[3]  Yoshiyuki Kobayashi,et al.  Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives. , 2002, Bioorganic & medicinal chemistry letters.

[4]  Satoru Kaneko,et al.  Synthesis and anti-influenza virus activity of 7-O-alkylated derivatives related to zanamivir. , 2002, Bioorganic & medicinal chemistry letters.

[5]  A J Elliott,et al.  BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. , 2000, Journal of medicinal chemistry.

[6]  K. Achiwa,et al.  Chemoenzymatic synthesis of an N-acetylneuraminic acid analogue having a carbamoylmethyl group at C-4 as an inhibitor of sialidase from influenza virus. , 1998, Carbohydrate research.

[7]  A Merritt,et al.  Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides. , 1998, Journal of medicinal chemistry.

[8]  A. Kuboki,et al.  AN EXPEDITIOUS ROUTE TO N-GLYCOLYLNEURAMINIC ACID BASED ON ENZYME-CATALYZED REACTION , 1997 .

[9]  W G Laver,et al.  Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. , 1997, Journal of the American Chemical Society.

[10]  K. Achiwa,et al.  Chemoenzymatic synthesis of neuraminic acid analogs structurally varied at C-5 and C-9 as potential inhibitors of the sialidase from influenza virus. , 1996, Carbohydrate research.

[11]  Paul W Smith,et al.  Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-guanidino-Neu5Ac2en (GG167) with modified 5-substituents , 1996 .

[12]  M. Itzstein,et al.  Synthesis of 4-substituted-2-acetamido-2,4-dideoxy-mannopyranoses using 1,6-anhydro sugar chemistry , 1995 .

[13]  Taylor Nr,et al.  Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis. , 1994 .

[14]  R. Bernacki,et al.  Fluorinated carbohydrates as potential plasma membrane modifiers. Synthesis of 3-deoxy-3-fluoro derivatives of 2-acetamido-2-deoxy-D-hexopyranoses. , 1990, Carbohydrate research.

[15]  E. Schreiner,et al.  Structural variations of N-acetylneuraminic acid, 15. Synthesis of 9-deoxy-, 7,9-dideoxy-, and 4,7,9-trideoxy-N-acetylneuraminic acid and their behaviour towards CMP-sialate synthase , 1990 .

[16]  M. Hartmann,et al.  Structural variations of N-acetylneuraminic acid, 14. Synthesis of the β-methyl ketosides of 4-oxo-, 7-oxo-, and 8-oxo-N-acetylneuraminic acid and the corresponding 7,7- and 8,8-dimethoxy derivatives their behaviour towards CMP-sialate synthase , 1990 .

[17]  D. Landini,et al.  Tetrabutylammonium dihydrogentrifluoride: an efficient catalyst for regio and stereoselective conversion of epoxides to fluorohydrins under solid-liquid phase-transfer catalysis conditions. , 1990 .

[18]  G. Whitesides,et al.  Membrane-enclosed enzymic catalysis (MEEC): a useful, practical new method for the manipulation of enzymes in organic synthesis , 1987 .

[19]  E. Zbiral,et al.  Strukturelle Abwandlungen an N‐Acetylneuraminsäure, 6. Synthesen von 7‐Oxo‐ und 8‐Oxo‐N‐acetylneuraminsäure‐Derivaten , 1987 .

[20]  M. Flashner,et al.  Mechanism of Arthrobacter sialophilus neuraminidase: the binding of substrates and transition-state analogs. , 1978, Biochemical and biophysical research communications.

[21]  H. Arita,et al.  Studies on Amino-hexoses. XVI. Synthesis of Deoxy-analogues of N -Acetyl- D -glucosamine , 1972 .